Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 709

1.

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.

J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.

PMID:
20945400
2.

Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.

Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA.

J Cell Physiol. 2009 Dec;221(3):771-7. doi: 10.1002/jcp.21920.

PMID:
19746436
4.

Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.

Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P.

Mol Cell Endocrinol. 2008 Jul 16;289(1-2):38-48. doi: 10.1016/j.mce.2008.03.005. Epub 2008 Mar 25.

PMID:
18455292
5.

Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.

Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N.

Mol Pharmacol. 2006 May;69(5):1615-23. Epub 2006 Feb 23.

6.

Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.

Liu H, Lee ES, Gajdos C, Pearce ST, Chen B, Osipo C, Loweth J, McKian K, De Los Reyes A, Wing L, Jordan VC.

J Natl Cancer Inst. 2003 Nov 5;95(21):1586-97.

PMID:
14600091
7.
8.
9.

Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.

Int J Oncol. 2005 Aug;27(2):327-35.

PMID:
16010412
10.

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.

Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ.

Cancer Res. 2002 Sep 15;62(18):5365-9.

11.

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.

Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.

PMID:
15196705
12.

Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.

Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A, Sica G.

Anticancer Res. 2004 Sep-Oct;24(5A):2729-38.

13.
14.

Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling.

Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M.

J Cell Physiol. 2005 Apr;203(1):193-201.

PMID:
15389627
15.

17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.

Pandini G, Genua M, Frasca F, Squatrito S, Vigneri R, Belfiore A.

Cancer Res. 2007 Sep 15;67(18):8932-41. Erratum in: Cancer Res. 2007 Nov 1;67(21):10623.

17.

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.

Breast Cancer Res. 2007;9(6):R77.

18.

A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes.

Hattori Y, Kojima T, Kato D, Matsubara H, Takigawa M, Ishiguro N.

Biochem Biophys Res Commun. 2012 May 11;421(3):418-24. doi: 10.1016/j.bbrc.2012.03.111. Epub 2012 Mar 29.

PMID:
22480687
19.
20.

Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.

Kumar R, Verma V, Sarswat A, Maikhuri JP, Jain A, Jain RK, Sharma VL, Dalela D, Gupta G.

Invest New Drugs. 2012 Apr;30(2):582-93. doi: 10.1007/s10637-010-9620-2. Epub 2010 Dec 23.

PMID:
21181231

Supplemental Content

Support Center